AGMAVET
Gilad Varda
Application Filed: 2017-06-11
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87483703 |
| Registration Number | 5374959 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | M80 |
| Employee Name | HOWARD, PARKER WALDRIP |
Timeline
| 2011-12-27 | Date of First Use |
| 2017-06-11 | Application Filed |
| 2017-10-24 | Published for Opposition |
| 2018-01-09 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-01-09 | Status: Live/Registered |
| 2018-01-09 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Gilad Varda |
| Address | 531 Silent Siesta Dr. Henderson NV US 89015 |
| Legal Entity Type | Individual |
| Legal Entity State | US |
| Owner: | Gilad Gad |
| Address | 531 Silent Siesta Dr. Henderson NV US 89015 |
| Legal Entity Type | Individual |
| Legal Entity State | US |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Analgesic and muscle relaxant pharmaceutical preparations; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-epileptic pharmaceutical preparations; Anticonvulsants; Antidepressants; Chemotherapeutics; Clinical medical reagents; Dermatological pharmaceutical products; Dietary and nutritional supplements; Dietary and nutritional supplements containing agmatine; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement beverage for aiding nerve health; Dietary supplemental drinks; Dietary supplements; Dietary supplements also containing agmatine; Dietary supplements consisting primarily of agmatine; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for treating nerve damage; Feed supplements for pets; Food supplements; Food supplements for treating nerve damage; Gels, creams and solutions for dermatological use; Glaucoma agents; Health food supplements; Homeopathic pharmaceuticals for use in the treatment of neuropathy; Homeopathic supplements; Medicaments for promoting recovery from nerve injury; Medicated animal feed; Medicated creams for treating dermatological conditions; Medicated dermatological preparations and substances; Medicated lotions for treating dermatological conditions; Medicated skin care preparations; Medicated supplements for foodstuffs for animals; Medicinal creams for skin care; Medicinal preparations for neuropathy; Natural dietary supplements; Natural supplements for treating depression and anxiety; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for the treatment of neuropathy; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for promoting nerve health; Nutritional and dietary supplements formed and packaged as bars; Nutritional drinks for animals; Nutritional supplements; Nutritional supplements consisting primarily of agmatine; Nutritional supplements for promoting healthy nerves; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the form of capsules; Nutritional supplements in the nature of nutritionally fortified soft chews; Ocular pharmaceuticals; Oral analgesics; Pain relief medication; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of neuropathy; Pharmaceutical preparations for the treatment and prevention of neuropathy; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of neuropathy; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for neuropathy; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, elixirs for the treatment of neuropathy; Pharmaceutical products for skin care for animals; Pharmaceuticals, namely, psychotropics; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Preparation for the relief of pain; Psychotropics; Syrups for pharmaceutical purposes for the treatment of neuropathy; Therapeutic pharmaceutical for the treatment of neuropathy; Topical analgesic creams; Veterinary preparations for dog neuropathy; Veterinary preparations, namely, pain relief medication; Vitamins and dietary food supplements for animals |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-06-14 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-06-16 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-09-11 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-09-13 | 4 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-10-04 | 5 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-10-24 | 6 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-10-24 | 7 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2018-01-09 | 8 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-01-09 | 9 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2023-01-21 | 10 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-07-18 | 11 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2023-07-18 | 12 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2023-07-18 | 13 NA85 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 AGMAVET 87483703 5374959 Live/Registered |
Gilad Varda 2017-06-11 |
AGMAVET 87483703 5374959 Live/Registered |
Gilad Gad 2017-06-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 